On September 12th at 8 AM New York time a select group of investors from America, Europe, Asia and the Middle East will gather on a group-video-call. This exclusive session will focus on Cutting Edge Opportunities in MedTech: How Innovations Pave the Path For Better Patients Care.

After the opening exchange of insights, participants will take part in a deep dive into Cerhum — a company bringing innovation to maxillofacial surgery with highly osteoconductive, patient-specific bioceramic bone grafts. They developed and patented a new generation of macroporosity that gives our grafts and implants exceptional osteoconductive properties, offering a highly differentiated alternative to autografts and traditional PSIs made of polymer and titanium. Their solution MyBone has obtained full EU regulatory clearance and is delivering early recurring revenues from first niche indications.

Cerhum’s innovative approach combines unique expertise: mastering the material to obtain unmatched osteoconductivity, mastering the design shapes to integrate controlled porosity ensuring better therapeutic results, and mastering the manufacturing process to deliver high-precision biocompatible bone grafts.

They are currently raising €6M in a late seed round to capitalise on a strong clinical and go-to-market momentum.

The agenda of the gathering:

• An interactive round table where investors discuss overlooked areas in healthcare with high potential impact
• A live presentation of Cerhum: its technology, traction, and growth strategy
• A co-development session where investors contribute strategic input and explore synergies with the founding team
• A final round of one-to-one meetings between investors and Cerhum, as well as with each other, enabling direct follow-ups and alignment

Held via video group call on September 12, 2025, the session runs for 3 hours
(4-7 pm Dubai time, 8-11 am New York time and 2-5 pm Zurich time).